These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 8652975
1. [Recurrent vitreoretinal membranes in intravitreal silicon oil tamponade. Morphologic and immunohistochemical studies]. Heidenkummer HP, Messmer EM, Kampik A. Ophthalmologe; 1996 Apr; 93(2):121-5. PubMed ID: 8652975 [Abstract] [Full Text] [Related]
2. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases]. Heidenkummer HP, Kampik A. Fortschr Ophthalmol; 1991 Apr; 88(3):219-24. PubMed ID: 1889766 [Abstract] [Full Text] [Related]
3. [Intraocular silicone oil tamponade. A clinico-pathologic study of 36 enucleated eyes]. Knorr HL, Seltsam A, Holbach L, Naumann GO. Ophthalmologe; 1996 Apr; 93(2):130-8. PubMed ID: 8652977 [Abstract] [Full Text] [Related]
4. [Long-term outcome after silicone oil removal]. Pavlovic S, Dick B, Schmidt KG, Tomic Z, Latinovic S. Ophthalmologe; 1995 Oct; 92(5):672-6. PubMed ID: 8750994 [Abstract] [Full Text] [Related]
6. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications. Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD, HSO Study Group. Acta Ophthalmol Scand; 2007 Sep; 85(6):623-30. PubMed ID: 17408389 [Abstract] [Full Text] [Related]
7. [Usefulness of different silicone oils for intraocular tamponade]. Latecka-Krajewska B, Nawrocki J, Bogorodzki B. Klin Oczna; 1998 Sep; 100(5):295-300. PubMed ID: 9884526 [Abstract] [Full Text] [Related]
8. [Endotamponade with silicon oil in severe proliferative retinopathy with attached retina]. Hoerauf H, Roider J, Bopp S, Lucke K, Laqua H. Ophthalmologe; 1995 Oct; 92(5):657-62. PubMed ID: 8750991 [Abstract] [Full Text] [Related]
9. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR. Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876 [Abstract] [Full Text] [Related]
10. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Heidenkummer HP, Kampik A, Petrovski B. Retina; 1992 Nov; 12(1):52-8. PubMed ID: 1565872 [Abstract] [Full Text] [Related]
11. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes. Heidenkummer HP, Kampik A. Ger J Ophthalmol; 1992 Nov; 1(3-4):170-5. PubMed ID: 1483131 [Abstract] [Full Text] [Related]
12. [The predictive value of a classification for proliferative diabetic vitreoretinopathy]. Hesse L, Heller G, Kraushaar N, Wesp A, Schroeder B, Kroll P. Klin Monbl Augenheilkd; 2002 Nov; 219(1-2):46-9. PubMed ID: 11932810 [Abstract] [Full Text] [Related]
18. Retinal redetachment after silicone oil removal in proliferative vitreoretinopathy: a prognostic factor analysis. Lam RF, Cheung BT, Yuen CY, Wong D, Lam DS, Lai WW. Am J Ophthalmol; 2008 Mar; 145(3):527-533. PubMed ID: 18191093 [Abstract] [Full Text] [Related]
19. [Histopathological and ultrastructural characteristics of oil-associated complications in silicone oil-filled human eyes]. Zhong XF, Li YP, Lin JX, Zhang WX, Zheng JL, Ge J, Feng GG. Zhonghua Yan Ke Za Zhi; 2005 Jan; 41(1):31-6. PubMed ID: 15774111 [Abstract] [Full Text] [Related]